http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014525475-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6429 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-647 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-745 |
filingDate | 2012-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2014-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2014525475-A |
titleOfInvention | How to process clotting factors |
abstract | The present application relates to a method for purifying recombinant clotting factor proteins such as, for example, prothrombin (factor II). In some embodiments, the methods provide purified prothrombin that exhibits increased biological activity and decreased thrombin levels, thereby increasing the safety of prothrombin. A purified recombinant clotting factor protein is also provided. [Selection] Figure 1 |
priorityDate | 2011-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 76.